在乳腺癌中,CLDN6通过招募DLG1/PBK复合体来触发NRF2介导的铁亡

Da Qi1, Yan Lu2, Huinan Qu3

  • 1The Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, 126 Xinmin Avenue, Changchun, 130021, China.

Cell death & disease
|February 21, 2025
PubMed
概括

克劳丁6 (CLDN6) 通过调节NRF2通路,触发乳腺癌中的铁. 这一发现为预后和潜在的铁灭向治疗提供了一个新的生物标志物.